Mannkind (MNKD) Interest Coverage Ratio (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.15% |
| Dec 31, 2025 | -107.36% |
| Sep 30, 2025 | -25.49% |
| Jun 30, 2025 | 287.41% |
| Mar 31, 2025 | -71.71% |
| Dec 31, 2024 | 139.41% |
| Sep 30, 2024 | 158.10% |
| Jun 30, 2024 | -57.86% |
| Mar 31, 2024 | 121.92% |
| Dec 31, 2023 | 62.12% |
| Sep 30, 2023 | 623.11% |
| Jun 30, 2023 | 111.63% |
| Mar 31, 2023 | 52.72% |
| Dec 31, 2022 | -33.23% |
| Sep 30, 2022 | -10.98% |
| Jun 30, 2022 | 60.19% |
| Mar 31, 2022 | 10.64% |
| Dec 31, 2021 | -268.17% |
| Sep 30, 2021 | 27.22% |
| Jun 30, 2021 | -236.67% |
| Mar 31, 2021 | 74.71% |
| Dec 31, 2020 | 56.08% |
| Sep 30, 2020 | -18.30% |
| Jun 30, 2020 | -9.82% |
| Mar 31, 2020 | 40.20% |
| Dec 31, 2019 | -422.55% |
| Sep 30, 2019 | 89.04% |
| Jun 30, 2019 | 14.79% |
| Mar 31, 2019 | -82.79% |
| Dec 31, 2018 | 42.53% |
| Sep 30, 2018 | -80.54% |
| Jun 30, 2018 | 19.53% |
| Mar 31, 2018 | -6.47% |
| Dec 31, 2017 | -14.98% |
| Sep 30, 2017 | 6.42% |
| Jun 30, 2017 | -79.95% |
| Mar 31, 2017 | -84.20% |
| Dec 31, 2016 | -113.86% |
| Sep 30, 2016 | 720.45% |
| Jun 30, 2016 | 3.53% |
| Mar 31, 2016 | 94.21% |
| Dec 31, 2015 | -1,205.39% |
| Sep 30, 2015 | -7.75% |
| Jun 30, 2015 | -55.34% |
| Mar 31, 2015 | 29.61% |
| Dec 31, 2014 | 24.53% |
| Sep 30, 2014 | 75.47% |
| Jun 30, 2014 | -180.67% |
| Mar 31, 2014 | -151.60% |
| Dec 31, 2013 | 60.67% |
| Sep 30, 2013 | 28.64% |
| Jun 30, 2013 | -14.01% |
| Mar 31, 2013 | -406.32% |
| Dec 31, 2012 | 79.75% |
| Sep 30, 2012 | 19.87% |
| Jun 30, 2012 | -17.55% |
| Mar 31, 2012 | -22.78% |
| Dec 31, 2011 | 6.83% |
| Sep 30, 2011 | 16.69% |
| Jun 30, 2011 | 12.20% |
| Mar 31, 2011 | -38.92% |
| Dec 31, 2010 | 50.01% |
| Sep 30, 2010 | 26.31% |